PHAT - Phathom Pharmaceuticals expands existing loan and security deal with Hercules Capital
2023-12-14 10:06:03 ET
More on Hercules Capital, Phathom Pharmaceuticals, etc.
- Main Street Capital Vs. Hercules Capital: Why Choose?
- Hercules Capital: This 10% Yield Is Solidly Covered By NII (Upgrade)
- Hercules Capital: 10% Yield, My Largest BDC Position
- Phathom Pharma heartburn drug undergoes FDA review
- Hercules Capital NII of $0.52 beats by $0.03
For further details see:
Phathom Pharmaceuticals expands existing loan and security deal with Hercules Capital